NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Shareholders of record on Friday, January 25th will be given a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.16%. The ex-dividend date of this dividend is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.02. The pharmacy operator earned $47.27 billion during the quarter, compared to the consensus estimate of $47.22 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The company's revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.50 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health updated its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

18 Wall Street analysts have issued 12-month price targets for CVS Health's stock. Their forecasts range from $75.00 to $104.00. On average, they expect CVS Health's stock price to reach $91.8824 in the next year. This suggests a possible upside of 45.0% from the stock's current price. View Analyst Price Targets for CVS Health.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Press coverage about CVS stock has trended somewhat positive on Thursday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned news coverage about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term.

CVS Health saw a decline in short interest in the month of December. As of December 14th, there was short interest totalling 11,357,418 shares, a decline of 67.7% from the November 30th total of 35,182,217 shares. Based on an average daily trading volume, of 12,090,071 shares, the short-interest ratio is currently 0.9 days. Currently, 0.9% of the company's shares are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Retirement Systems of Alabama (0.13%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.08%), Gateway Investment Advisers LLC (0.08%), Alta Capital Management LLC (0.06%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Factory Mutual Insurance Co., Alta Capital Management LLC, Gulf International Bank UK Ltd, Endurance Wealth Management Inc., Legacy Advisors LLC, Altfest L J & Co. Inc. and Thomasville National Bank. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Personal Capital Advisors Corp, Gateway Investment Advisers LLC, KAMES CAPITAL plc, Retirement Systems of Alabama, Community Trust & Investment Co., Chesley Taft & Associates LLC, State of Alaska Department of Revenue and Nisa Investment Advisors LLC. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $63.37.

CVS Health has a market capitalization of $64.94 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]